Clinical Trial Update: Treatment With Local PPARgamma Ligand in Distal Ulcerative Colitis [Phase 1, Phase 2]

View source ↗

Summary

This document describes an ongoing Phase 1/Phase 2 clinical trial evaluating a local PPARgamma ligand for distal ulcerative colitis; no results are provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Local PPARgamma ligand

Snippet

Sponsor: Herlev Hospital | Conditions: Ulcerative Colitis | Phase 1, Phase 2 | Status: UNKNOWN